Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Revvity, Inc. Common Stock (NY:RVTY)

95.91 -2.40 (-2.44%)
Streaming Delayed Price Updated: 3:24 PM EST, Mar 2, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Revvity, Inc. Common Stock

< Previous 1 2 3 4 5 6 Next >
News headline image
Medpace, Revvity, Azenta, Bio-Techne, and Oscar Health Stocks Trade Down, What You Need To Know
A number of stocks fell in the morning session after the Trump administration's announcement of new global tariffs reignited trade policy uncertainty. The move came swiftly after the Supreme Court... 
Via StockStory
Topics Government World Trade
News headline image
3 Healthcare Stocks Walking a Fine Line
From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Shareholders who bet on the industry have been rewarded lately as healthcare... 
Via StockStory
Topics Stocks
News headline image
3 Unpopular Stocks We Think Twice About
When Wall Street turns bearish on a stock, it’s worth paying attention. These calls stand out because analysts rarely issue grim ratings on companies for fear their firms will lose out in other... 
Via StockStory
Revvity Inc (NYSE:RVTY) Beats Q4 Earnings Estimates, Provides In-Line 2026 Guidance ↗
Via Chartmill
Tuesday's pre-market session: top gainers and losers in the S&P500 index ↗
Via Chartmill
What's going on in today's session: S&P500 movers ↗
Via Chartmill
Gapping S&P500 stocks in Monday's session ↗
Via Chartmill
News headline image
Revvity (RVTY) Q4 2025 Earnings Call Transcript ↗
Revvity (RVTY) Q4 2025 Earnings Call Transcript 
Via The Motley Fool
Topics Earnings World Trade
Discover the top S&P500 movers in Monday's pre-market session. ↗
Via Chartmill
News headline image
Revvity’s (NYSE:RVTY) Q4 CY2025 Sales Beat Estimates
Life sciences company Revvity (NYSE:RVTY) reported revenue ahead of Wall Streets expectations in Q4 CY2025, with sales up 5.8% year on year to $772.1 million. The company’s full-year revenue guidance... 
Via StockStory
Topics Earnings
News headline image
Revvity (RVTY) Q4 Earnings: What To Expect
Life sciences company Revvity (NYSE:RVTY) will be announcing earnings results this Monday before market open. Here’s what you need to know. 
Via StockStory
Topics Artificial Intelligence
News headline image
Revvity Stock Gains On Solid Early Q4 Results, Upbeat Outlook ↗
Revvity, Inc. (NYSE: RVTY) stock rose on Tuesday after releasing preliminary expectations for Q4 and FY 2025. 
Via Benzinga
These S&P500 stocks are moving in today's session ↗
Via Chartmill
Stay informed with the top movers within the S&P500 index on Tuesday. ↗
Via Chartmill
These S&P500 stocks are moving in today's pre-market session ↗
Via Chartmill
News headline image
3 Cash-Producing Stocks That Concern Us
While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient spending, slowing demand, or weak... 
Via StockStory
Topics Supply Chain
News headline image
Q3 Earnings Highlights: Revvity (NYSE:RVTY) Vs The Rest Of The Research Tools & Consumables Stocks
The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how Revvity (NYSE:RVTY) and the... 
Via StockStory
Topics Economy
News headline image
3 Reasons RVTY is Risky and 1 Stock to Buy Instead
Revvity currently trades at $96.77 per share and has shown little upside over the past six months, posting a middling return of 2.5%. The stock also fell short of the S&P 500’s 13.6% gain during that... 
Via StockStory
Topics Stocks
News headline image
Gapping S&P500 stocks in Thursday's session ↗
Curious about the market action on Thursday? Dive into the US markets to explore the gap up and gap down stocks in the S&P500 index during today's session. 
Via Chartmill
News headline image
3 Unpopular Stocks with Open Questions
Wall Street’s bearish price targets for the stocks in this article signal serious concerns. Such forecasts are uncommon in an industry where maintaining cordial corporate relationships often trumps... 
Via StockStory
News headline image
Stay updated with the stocks that are on the move in today's after-hours session. ↗
Wondering what's happening in today's after-hours session? Stay tuned for the latest updates on stock movements. 
Via Chartmill
News headline image
Which S&P500 stocks are moving on Tuesday? ↗
Stay informed about the performance of the S&P500 index one hour before the close of the markets on Tuesday. Uncover the top gainers and losers in today's session for valuable insights. 
Via Chartmill
News headline image
Explore the top gainers and losers within the S&P500 index in today's session. ↗
Let's delve into the developments on the US markets in the middle of the day on Tuesday. Below, you'll find the top gainers and losers within the S&P500 index during today's session. 
Via Chartmill
News headline image
Option Care Health, DaVita, Revvity, West Pharmaceutical Services, and Bausch + Lomb Shares Skyrocket, What You Need To Know
A number of stocks jumped in the afternoon session after comments from a key Federal Reserve official bolstered hopes for an interest rate cut. New York Federal Reserve President John Williams stated... 
Via StockStory
Topics Economy
News headline image
1 of Wall Street’s Favorite Stock with Exciting Potential and 2 We Ignore
Wall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside potential. However, it’s worth remembering that analysts rarely issue sell ratings,... 
Via StockStory
News headline image
3 Cash-Producing Stocks That Fall Short
Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it effectively, leading to missed opportunities. 
Via StockStory
News headline image
5 Insightful Analyst Questions From Revvity’s Q3 Earnings Call
Revvity’s third quarter results were met with a significant negative reaction from the market, as investors focused on sluggish organic revenue growth and margin compression despite headline results... 
Via StockStory
Topics Earnings
News headline image
Revvity Analysts Increase Their Forecasts After Q3 Earnings ↗
 
Via Benzinga
News headline image
RVTY Q3 Deep Dive: AI Initiatives and Segment Divergence Shape Outlook
Life sciences company Revvity (NYSE:RVTY) met Wall Street’s revenue expectations in Q3 CY2025, with sales up 2.2% year on year to $698.9 million. The company’s outlook for the full year was close to... 
Via StockStory
Topics Artificial Intelligence
News headline image
These S&P500 stocks are moving in today's session ↗
Stay updated with the movement of S&P500 stocks in today's session. Discover which S&P500 stocks are making waves on Monday. 
Via Chartmill
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.